Orchid Chemicals commences operations of bulk drugs plant at Alanthur
The company has now recommenced the operations in a phased manner08-12-2015
08-12-2015
Updates
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that production operations of the Company's Bulk Drugs Plant located at Alathur, Tamil Nadu have been disrupted from December 02, 2015, due to flooding at the factory premises caused by heavy rains in Chennai.The Company have now recommenced the operations in a phased manner. However, the Sterile Manufacturing Section would need to be verified for Sterility and this would take a few more days for becoming fully operational....08-12-2015
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
R Vijayalakshmi, K Raghavendra Rao (POA of R Sowmya), R Divya & Orchid Health Care Pvt Ltd has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE01-12-2015
Financial Results with Results Press Release & Limited Review Report for Sept 30, 2015 (Standalone)
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE about the Standalone Financial Results, Results Press Release & a copy of the Limited Review Report for the period ended September 30, 2015.09-11-2015
Change of Name of the Company
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that the members of the Company at the Annual General Meeting held on September 15, 2015 have approved to change the name of the Company to "Orchid Pharma Limited" and the special resolution was passed with requisite majority.Based on this, the Company had made an application to the Registrar of Companies, Tamilnadu, for change of name and the Registrar of Companies have approved the...26-10-2015
Shareholding Pattern for September 30, 2015
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE about the Shareholding Pattern as on September 30, 2015.20-10-2015
Outcome of Allotment Committee Meeting
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE that the Allotment Committee of the Board of Directors at their meeting held on October 09, 2015 has allotted 3,702,450 equity shares of Rs. 10/- each at a price of Rs. 49.79/- (Including a premium of Rs. 39.79/- per share) as the second and final tranche to the Promoter group Company M/s. Orchid Healthcare Private Limited on Preferential Basis as per the Corporate Debt Restructuring (CDR) Scheme...09-10-2015
Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011
K Raghavendra Rao has submitted the disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 to BSE29-09-2015
Updates on Outcome of AGM
Orchid Chemicals & Pharmaceuticals Ltd has submitted to BSE a copy of Proceedings of the 22nd Annual General Meeting (AGM) of the Company held on September 15, 2015 along with a copy of Chairman's Speech.24-09-2015
Disclosure of Voting results of AGM (Clause 35A)
Orchid Chemicals & Pharmaceuticals Ltd has informed BSE regarding the details of Voting results at the Annual General Meeting (AGM) of the Company held on September 15, 2015, under Clause 35A of Listing Agreement along with Scrutinizer's Report in this regard.17-09-2015